GNPX vs LOW · $5.3M cap vs P/E 18, rev $86.29B
Genprex Inc (GNPX) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
Genprex Inc (GNPX) is a biotechnology company listed on NASDAQ.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported GNPX revenue for 2024-12-31 was $0. Net income was -$21.1M. GNPX currently screens at market cap $5.3M.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
GNPX currently screens at market cap $5.3M. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the GNPX and LOW stock pages for the full models.
Not investment advice.